Through the analysis of differential mRNA expressions, prognosis, risk prediction, and other indicators, combined with PPI protein network analysis, we found that SERPINE1 may be a key gene regulating EMT in glioblastoma. This evidence concerns the gene SERPINE1 and glioblastoma.